PROCEPT BioRobotics Corp Files 8-K

Ticker: PRCT · Form: 8-K · Filed: May 3, 2024 · CIK: 1588978

Sentiment: neutral

Topics: disclosure, filing

TL;DR

PROCEPT BioRobotics filed an 8-K, standard disclosure stuff, no major news.

AI Summary

PROCEPT BioRobotics Corporation filed an 8-K on May 3, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.

Why It Matters

This 8-K filing indicates PROCEPT BioRobotics Corporation is providing standard disclosures and financial exhibit information to the SEC.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new material risks or events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by PROCEPT BioRobotics Corporation?

The primary purpose of this 8-K filing is to report on a Regulation FD Disclosure and Financial Statements and Exhibits.

On what date was this 8-K report filed?

The report was filed on May 3, 2024.

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is PROCEPT BIOROBOTICS CORPORATION.

Where are PROCEPT BioRobotics Corporation's principal executive offices located?

PROCEPT BioRobotics Corporation's principal executive offices are located at 150 Baytech Drive, San Jose, California 95134.

What is the SEC File Number for PROCEPT BioRobotics Corporation?

The SEC File Number for PROCEPT BioRobotics Corporation is 001-40797.

Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-05-03 08:57:30

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure Beginning on Ma y 3, 2024, re presentatives of PROCEPT BioRobotics Corporation (the "Company") intend to make presentations at investor conferences and in other forums. These presentations may include the information contained in Exhibit 99.1 furnished to this Current Report on Form 8-K. A copy of certain of the presentation slides containing such information that may be disclosed by the Company is furnished as Exhibit 99.1 to this report and is incorporated herein by reference and constitutes a part of this report. The information included under Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Presentation of PROCEPT BioRobotics Corporation, dated May 3 , 2024 . 104 Cover Page Interactive Data File, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCEPT BIOROBOTICS CORPORATION Date: May 3, 2024 By: /s/ Alaleh Nouri Alaleh Nouri EVP, Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing